{"id":782383,"date":"2023-09-07T06:42:58","date_gmt":"2023-09-07T10:42:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/"},"modified":"2023-09-07T06:42:58","modified_gmt":"2023-09-07T10:42:58","slug":"affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/","title":{"rendered":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">HEIDELBERG, Germany, Sept.  07, 2023  (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the H.C. Wainwright 25<sup>th<\/sup> Annual Global Investment Conference on Tuesday, September 12, 2023 at 11:00 a.m. Eastern Daylight Time \/ 17:00 Central European Time.<\/p>\n<p>A live webcast of the presentation will be accessible on Affimed\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JjVymHRjZw9yVDZHUcK8jnfNN-kjCafkbSvFRfdcANN5Sr0AK2pLi6m-AwdRGnQfGkJoZ_yKCt6RgoJVueNy-hd6AP5ivQIu2cLsux-kzIlDdHKSWc9NpNszsRLzUU8A2AhPRC4dbeNzK5VtiZ6-PkqVqz-lEYJ85P6JmwrRPn7XAGY5zBWmN3RAGaXbZFUvFF5yRucCyxRyWvktXoKcfDO9_ttp2wPTrr04xjsT860=\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/<\/u><\/a>. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call.<\/p>\n<p>For more information on the conference or to schedule a one-on-one meeting with Affimed management, please contact your conference representative, or Alex Fudukidis via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cVqTb4BMYXdbCcemOrgRnflvl_-SSHixsFiPPbnBZ6HuOqn4QKQ6BssVdnU0S4X7_fuU9QDCi2HPVM9Qf6LVlqw8ztA_QNbr6-UZVj-qnDY=\" rel=\"nofollow noopener\" target=\"_blank\"><u>a.fudukidis@affimed.com<\/u><\/a> or phone at +1 (917) 436-8102.<\/p>\n<p align=\"justify\">\n        <strong>About Affimed N.V.<\/strong><br \/>\n        <br \/>Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The Company\u2019s proprietary ROCK<sup>\u00ae<\/sup> platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK<sup>\u00ae<\/sup> platform predictably generates customized innate cell engager (ICE<sup>\u00ae<\/sup>) molecules, which use patients\u2019 immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE<sup>\u00ae<\/sup>. Headquartered in Heidelberg, Germany, with offices in New York, NY, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients\u2019 lives. For more about the Company\u2019s people, pipeline and partners, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y5xxNtKHOnrAzWO7IXoFRRkicdpyTqDidJu6hH_wRyHOwxiYS5M5InD4TWgXtCyRZCCwzftGEtwkoOkeshI5Sg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.affimed.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Affimed Investor Contact<\/strong><br \/>\n        <br \/>Alexander Fudukidis<br \/>Director, Head of Investor Relations<br \/>E-Mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cVqTb4BMYXdbCcemOrgRnflvl_-SSHixsFiPPbnBZ6HARoZ3qOEAwhk9md96ZzN7sKngoFemWM94tjW6flVD9LuBaRYt7zKn4DckVQOAj1E=\" rel=\"nofollow noopener\" target=\"_blank\"><u>a.fudukidis@affimed.com<\/u><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b4EY6m6lda-bItPSBV0bf0tTZ42Q9AsGRvABiaPRhbny8nbp86jkKwCm7uPbLXuB5PQGh5fk0-wFXAVM1sIDvg==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a>Tel.: +1 (917) 436-8102<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTU4Y2Y3YWMtNWQ3MC00NTI3LTlkYWYtNTBkMWNlYWQ4NTQ0LTEwMTUzMDc=\/tiny\/Affimed-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 11:00 a.m. Eastern Daylight Time \/ 17:00 Central European Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed management, please contact your conference representative, or Alex Fudukidis via email at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Affimed to Present at the H.C. Wainwright Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-782383","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 11:00 a.m. Eastern Daylight Time \/ 17:00 Central European Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed management, please contact your conference representative, or Alex Fudukidis via email at &hellip; Continue reading &quot;Affimed to Present at the H.C. Wainwright Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-07T10:42:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference\",\"datePublished\":\"2023-09-07T10:42:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/\",\"name\":\"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\",\"datePublished\":\"2023-09-07T10:42:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","og_description":"HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 11:00 a.m. Eastern Daylight Time \/ 17:00 Central European Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed management, please contact your conference representative, or Alex Fudukidis via email at &hellip; Continue reading \"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-07T10:42:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference","datePublished":"2023-09-07T10:42:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/","name":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=","datePublished":"2023-09-07T10:42:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE1MSM1ODAyOTcwIzIwMDM3MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-h-c-wainwright-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Affimed to Present at the H.C. Wainwright Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=782383"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782383\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=782383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=782383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=782383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}